Home » Topics » BioWorld Science

BioWorld Science
RSS

IFI27 as a potential new gene biomarker for severe COVID-19

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

P38 targeting reverses immunosuppressive tumor microenvironment in metastatic breast cancer

Dec. 21, 2021

Novel XO inhibitors show efficacy in acute hyperuricemia rat model

Dec. 21, 2021

Mouse model of metaplastic breast cancer with conditional overexpression of TRIM24

Dec. 21, 2021

MCC-1734 inhibits cancer cells with different resistance mechanisms

Dec. 21, 2021

IpY.20 targets p27Kip1 to evade breast cancer resistance driven by CDK4 and CDK2

Dec. 21, 2021

CLIP-170S confers resistance to taxane-based therapy in gastric cancer

Dec. 21, 2021

JAK inhibitors divulged by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical

Dec. 21, 2021

Biopolar Hongye presents new Janus kinase inhibitors

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...